Bone regeneration is inhibited by myeloma-associated secreted inhibitors like DKK-1, secreted frizzled related proteins 2 and 3 (SFRP2/3), SOST and activin which interfere with osteogenic differentiation pathways[26,27]. Here, SFRP2 is linked to plasma cell myeloma.